These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3469997)

  • 21. Chemotherapy for advanced or recurrent gynecologic cancer.
    Thigpen T; Vance R; Lambuth B; Balducci L; Khansur T; Blessing J; McGehee R
    Cancer; 1987 Oct; 60(8 Suppl):2104-16. PubMed ID: 3308070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy sensitivity of gynecologic malignancies determined by the human tumor stem cell assay (HTSCA)].
    Obi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):792-8. PubMed ID: 3598274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.
    Rogers PM; Beale PJ; Al-Moundhri M; Boxall F; Patterson L; Valenti M; Raynaud F; Hobbs S; Johnston S; Kelland LR
    Int J Cancer; 2002 Feb; 97(6):858-63. PubMed ID: 11857368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay.
    Zirvi KA; Hill GJ; Hill HZ
    J Surg Oncol; 1986 Feb; 31(2):123-6. PubMed ID: 3713188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
    Tsuruo T; Hamilton TC; Louie KG; Behrens BC; Young RC; Ozols RF
    Jpn J Cancer Res; 1986 Sep; 77(9):941-5. PubMed ID: 2429947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z; Pásti G; Lampé L; Juhász B
    Zentralbl Gynakol; 1985; 107(17):1065-71. PubMed ID: 4060913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D
    Clin Obstet Gynaecol; 1978 Dec; 5(3):709-27. PubMed ID: 367674
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemosensitivity test for gynecologic malignancies by in vitro colony assay].
    Kano T; Nishida Y; Sakakibara K; Ohta M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2827-36. PubMed ID: 4086909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity.
    Kelland LR; Tonkin KS
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1211-8. PubMed ID: 2475347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro chemosensitivity of J-82 human bladder cancer cells.
    Anderson KC; Simpson WG; Ballou RJ; Harty JI; Tseng MT
    Urol Res; 1986; 14(3):141-4. PubMed ID: 3750594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
    Bénard J; Riou G
    Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
    Parker RL; Welander CE; Homesley HD; Jobson VW; Kawamoto EH
    Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experiences with in vitro testing of chemotherapeutic agents].
    Axhausen M; Matthias R
    HNO; 1985 Aug; 33(8):374-6. PubMed ID: 2412996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms].
    Koto T; Tsunawaki A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):4262-76. PubMed ID: 3729501
    [No Abstract]   [Full Text] [Related]  

  • 37. cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.
    Wilson AP; Ford CH; Newman CE; Howell A
    Br J Cancer; 1987 Dec; 56(6):763-73. PubMed ID: 3435704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytostatic treatment of genital carcinoma].
    Limburg H
    Zentralbl Gynakol; 1969 Sep; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of a human endometrial carcinoma cell line (RL-95) for in vitro testing of chemotherapeutic agents.
    Christensen C; Deppe G; Saunders D; Malviya V
    Gynecol Oncol; 1987 Sep; 28(1):25-33. PubMed ID: 3653767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution and clinical application of a rapid chemosensitivity assay.
    Sondak VK; Bertelsen CA; Kern DH; Morton DL
    Cancer; 1985 Mar; 55(6):1367-71. PubMed ID: 3971305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.